Mitochondrial Replacement by Genome Transfer in Human Oocytes: Efficacy, Concerns, and Legality

Overview

Journal Reprod Med Biol

Specialty Biology

Date 2021 Jan 25

PMID 33488283

Citations 9

Authors

Mitsutoshi Yamada

Suguru Sato

Reina Ooka

Kazuhiro Akashi

Akihiro Nakamura

Kenji Miyado

Hidenori Akutsu

Mamoru Tanaka

Affiliations

Soon will be listed here.

Abstract

Background: Pathogenic mitochondrial (mt)DNA mutations, which often cause life-threatening disorders, are maternally inherited via the cytoplasm of oocytes. Mitochondrial replacement therapy (MRT) is expected to prevent second-generation transmission of mtDNA mutations. However, MRT may affect the function of respiratory chain complexes comprised of both nuclear and mitochondrial proteins.

Methods: Based on the literature and current regulatory guidelines (especially in Japan), we analyzed and reviewed the recent developments in human models of MRT.

Main Findings: MRT does not compromise pre-implantation development or stem cell isolation. Mitochondrial function in stem cells after MRT is also normal. Although mtDNA carryover is usually less than 0.5%, even low levels of heteroplasmy can affect the stability of the mtDNA genotype, and directional or stochastic mtDNA drift occurs in a subset of stem cell lines (mtDNA genetic drift). MRT could prevent serious genetic disorders from being passed on to the offspring. However, it should be noted that this technique currently poses significant risks for use in embryos designed for implantation.

Conclusion: The maternal genome is fundamentally compatible with different mitochondrial genotypes, and vertical inheritance is not required for normal mitochondrial function. Unresolved questions regarding mtDNA genetic drift can be addressed by basic research using MRT.

Citing Articles

Abnormalities of Oocyte Maturation: Mechanisms and Implications.

Baldini G, Lot D, Malvasi A, Lagana A, Vimercati A, Dellino M Int J Mol Sci. 2024; 25(22).

PMID: 39596263 PMC: 11595025. DOI: 10.3390/ijms252212197.

Clinical Approaches for Mitochondrial Diseases.

Hong S, Kim S, Kim K, Lee H Cells. 2023; 12(20).

PMID: 37887337 PMC: 10605124. DOI: 10.3390/cells12202494.

Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction.

Smits M, Schomakers B, van Weeghel M, Wever E, Wust R, Dijk F Hum Reprod. 2023; 38(11):2208-2220.

PMID: 37671592 PMC: 10628503. DOI: 10.1093/humrep/dead177.

Mitochondria Have Made a Long Evolutionary Path from Ancient Bacteria Immigrants within Eukaryotic Cells to Essential Cellular Hosts and Key Players in Human Health and Disease.

Atlante A, Valenti D Curr Issues Mol Biol. 2023; 45(5):4451-4479.

PMID: 37232752 PMC: 10217700. DOI: 10.3390/cimb45050283.

Earlier second polar body transfer and further mitochondrial carryover removal for potential mitochondrial replacement therapy.

Li W, Liao X, Lin K, Cai R, Guo H, Ma M MedComm (2020). 2023; 4(3):e217.

PMID: 37180823 PMC: 10167372. DOI: 10.1002/mco2.217.

References

Zhang J, Liu H, Luo S, Lu Z, Chavez-Badiola A, Liu Z . Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online. 2017; 34(4):361-368. DOI: 10.1016/j.rbmo.2017.01.013. View

Monnot S, Gigarel N, Samuels D, Burlet P, Hesters L, Frydman N . Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system. Hum Mutat. 2010; 32(1):116-25. PMC: 3058134. DOI: 10.1002/humu.21417. View

Wang T, Sha H, Ji D, Zhang H, Chen D, Cao Y . Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell. 2014; 157(7):1591-604. DOI: 10.1016/j.cell.2014.04.042. View

Sharpley M, Marciniak C, Eckel-Mahan K, McManus M, Crimi M, Waymire K . Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition. Cell. 2012; 151(2):333-343. PMC: 4175720. DOI: 10.1016/j.cell.2012.09.004. View

Paull D, Emmanuele V, Weiss K, Treff N, Stewart L, Hua H . Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature. 2012; 493(7434):632-7. PMC: 7924261. DOI: 10.1038/nature11800. View

Sutovsky P, Moreno R, Ramalho-Santos J, Dominko T, Simerly C, Schatten G . Ubiquitin tag for sperm mitochondria. Nature. 1999; 402(6760):371-2. DOI: 10.1038/46466. View

Lee H, Ma H, Juanes R, Tachibana M, Sparman M, Woodward J . Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck. Cell Rep. 2012; 1(5):506-15. PMC: 3372871. DOI: 10.1016/j.celrep.2012.03.011. View

Hecht N, Liem H, Kleene K, Distel R, Ho S . Maternal inheritance of the mouse mitochondrial genome is not mediated by a loss or gross alteration of the paternal mitochondrial DNA or by methylation of the oocyte mitochondrial DNA. Dev Biol. 1984; 102(2):452-61. DOI: 10.1016/0012-1606(84)90210-0. View

Leaver M, Wells D . Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics?. Hum Reprod Update. 2019; 26(1):16-42. DOI: 10.1093/humupd/dmz033. View

10.

Luo S, Valencia C, Zhang J, Lee N, Slone J, Gui B . Biparental Inheritance of Mitochondrial DNA in Humans. Proc Natl Acad Sci U S A. 2018; 115(51):13039-13044. PMC: 6304937. DOI: 10.1073/pnas.1810946115. View

11.

Wallace D, Singh G, Lott M, Hodge J, Schurr T, Lezza A . Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988; 242(4884):1427-30. DOI: 10.1126/science.3201231. View

12.

Handyside A, Kontogianni E, Hardy K, Winston R . Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990; 344(6268):768-70. DOI: 10.1038/344768a0. View

13.

Steffann J, Gigarel N, Samuels D, Monnot S, Borghese R, Hesters L . Data from artificial models of mitochondrial DNA disorders are not always applicable to humans. Cell Rep. 2014; 7(4):933-4. DOI: 10.1016/j.celrep.2014.05.005. View

14.

Hudson G, Takeda Y, Herbert M . Reversion after replacement of mitochondrial DNA. Nature. 2019; 574(7778):E8-E11. DOI: 10.1038/s41586-019-1623-3. View

15.

Craven L, Tuppen H, Greggains G, Harbottle S, Murphy J, Cree L . Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature. 2010; 465(7294):82-5. PMC: 2875160. DOI: 10.1038/nature08958. View

16.

Simon A, Kiehl M, Fischer E, Proctor J, Bush M, Givens C . Pregnancy outcomes from more than 1,800 in vitro fertilization cycles with the use of 24-chromosome single-nucleotide polymorphism-based preimplantation genetic testing for aneuploidy. Fertil Steril. 2018; 110(1):113-121. DOI: 10.1016/j.fertnstert.2018.03.026. View

17.

Floros V, Pyle A, Dietmann S, Wei W, Tang W, Irie N . Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos. Nat Cell Biol. 2018; 20(2):144-151. PMC: 6551220. DOI: 10.1038/s41556-017-0017-8. View

18.

Yamada M, Sato S, Ooka R, Akashi K, Nakamura A, Miyado K . Mitochondrial replacement by genome transfer in human oocytes: Efficacy, concerns, and legality. Reprod Med Biol. 2021; 20(1):53-61. PMC: 7812462. DOI: 10.1002/rmb2.12356. View

19.

Lee H, McCulloh D, Hodes-Wertz B, Adler A, McCaffrey C, Grifo J . In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43. J Assist Reprod Genet. 2015; 32(3):435-44. PMC: 4363234. DOI: 10.1007/s10815-014-0417-7. View

20.

Schaefer A, McFarland R, Blakely E, He L, Whittaker R, Taylor R . Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2007; 63(1):35-9. DOI: 10.1002/ana.21217. View